Distribuzione geografica
Continente #
NA - Nord America 3786
EU - Europa 468
AS - Asia 376
Continente sconosciuto - Info sul continente non disponibili 3
AF - Africa 1
Totale 4634
Nazione #
US - Stati Uniti d'America 3783
CN - Cina 260
SE - Svezia 142
IT - Italia 114
VN - Vietnam 99
FI - Finlandia 96
UA - Ucraina 62
DE - Germania 39
IN - India 16
GB - Regno Unito 8
EU - Europa 3
CA - Canada 2
FR - Francia 2
NL - Olanda 2
CH - Svizzera 1
HK - Hong Kong 1
NO - Norvegia 1
PR - Porto Rico 1
SC - Seychelles 1
SI - Slovenia 1
Totale 4634
Città #
Fairfield 624
Woodbridge 502
Ann Arbor 434
Chandler 382
Jacksonville 253
Houston 248
Ashburn 240
Wilmington 238
Seattle 197
Cambridge 196
Dong Ket 99
Princeton 96
Beijing 79
Roxbury 75
San Diego 69
Medford 67
Padova 56
Nanjing 54
Des Moines 39
Helsinki 36
Boardman 30
Jinan 21
Nanchang 18
Shenyang 17
Falls Church 15
Hebei 14
Jiaxing 9
Changsha 8
Tianjin 8
Norwalk 6
San Donà Di Piave 6
Taizhou 6
Zhengzhou 4
Guangzhou 3
Kharkiv 3
Kunming 3
Ningbo 3
Philadelphia 3
Fuzhou 2
Haikou 2
Hefei 2
Indiana 2
Las Vegas 2
Rockville 2
Andrano 1
Barletta 1
Borås 1
Buffalo 1
Caguas 1
Central District 1
Chicago 1
Dallas 1
Ferentino 1
Grafing 1
Hangzhou 1
Lancenigo-Villorba 1
Lanzhou 1
Mahé 1
Mogliano Veneto 1
Mugnano Di Napoli 1
New York 1
Oslo 1
Piano Di Sorrento 1
Redmond 1
Redwood City 1
Sacile 1
San Francisco 1
Toronto 1
Trieste 1
Venezia 1
Wettingen 1
Totale 4200
Nome #
Dual polarization of human alveolar macrophages progressively increases with smoking and COPD severity 160
Reassessing the Role of Eosinophils as a Biomarker in Chronic Obstructive Pulmonary Disease 127
Early Airway Pathological Changes in Children: New Insights into the Natural History of Wheezing 124
High-Resolution CT Change over Time in Patients with Idiopathic Pulmonary Fibrosis on Antifibrotic Treatment 122
Airway inflammation in childhood asthma 116
Immune inflammation and disease progression in idiopathic pulmonary fibrosis 111
Clinical and pathologic factors predicting future Asthma in wheezing children: A longitudinal study 109
Predictors of response to pirfenidone treatment in patients with idiopathic pulmonary fibrosis (IPF) 108
Nonatopic children with multitrigger wheezing have airway pathology comparable to atopic asthma 104
Exome Sequencing Reveals Immune Genes as Susceptibility Modifiers in Individuals with α1-Antitrypsin Deficiency 103
Deficient antiviral immune responses in childhood: Distinct roles of atopy and asthma. 98
Increased activation of p38 MAPK in COPD 96
Deficient Immune Response to Viral Infections in Children Predicts Later Asthma Persistence 92
Alpha-1 antitrypsin deficiency: Beyond the protease/antiprotease paradigm 85
Epithelial damage and angiogenesis in the airways of children with asthma. 84
High-Resolution Computed Tomography (HRCT) Reflects Disease Progression in Patients with Idiopathic Pulmonary Fibrosis (IPF): Relationship with Lung Pathology 82
Characterization of the Immune Response in COPD: Study of IL-32 Expression in AAT Deficient and AAT Replete Patients 80
Role of Ca2+ and protein kinase C in the serotonin (5-HT) transport in human platelets 79
Alpha-1 antitrypsin deficiency today: New insights in the immunological pathways 79
IL-32, a Novel Proinflammatory Cytokine in Chronic Obstructive Pulmonary Disease 78
Do Cytokine Expression and Airway Remodeling in Asthma Depend on Eosinophilic Inflammation? 77
Matrix metalloproteinase-2 protein in lung periphery is related to COPD progression 76
Neutrophilic infiltration within the airway smooth muscle in patients with COPD 75
Blood eosinophilia neither reflects tissue eosinophils nor worsens clinical outcomes in chronic obstructive pulmonary disease 69
Upregulation of Decoy receptor D6 in COPD 67
Mast Cell Infiltration Discriminates Between Histopathological Phenotypes of Chronic Obstructive Pulmonary Disease. 65
Non-eosinophilic asthma in children: relation with airway remodeling 65
Lymphoid follicles in end-stage emphysema: Comparison of patients with or without α1-antitrypsin deficiency. European Respiratory Society Annual Congress Barcellona, Spain, September 19-22, 2010. 64
Blood eosinophils relate to atopy and not to tissue eosinophils in wheezing children 63
A Novel Insight into Adaptive Immunity in Chronic Obstructive Pulmonary Disease B Cell Activating Factor Belonging to the Tumor Necrosis Factor Family 62
Airway pathology and symptom evolution in wheezing children 61
Pretreatment rate of decay in forced vital capacity predicts long-term response to pirfenidone in patients with idiopathic pulmonary fibrosis 60
B Cell Activating Factor (BAFF) Is Expressed by Lymphoid Follicles of COPD Patients 58
Airway remodeling is present in children with asthma regardless of eosinophilic inflammation. 57
Airway remodelling and TGFβ signalling in children with eosinophilic and non-eosinophilic asthma. 55
Transforming growth factor-beta type II receptor in pulmonary arteries of patients with very severe COPD 54
Basi Strutturali della BPCO 53
Critical review of the evolution of extracellular vesicles’ knowledge: From 1946 to today 52
Upregulation of myeloid derived suppressor cells (MDSCs) in chronic obstructive pulmonary disease and its relationship with disease severity 51
Decreased expression of TGF-beta type II receptor in bronchial glands of smokers with COPD 51
Risk Factors for Development and Severity of COVID-19 in COPD Patients 51
Pathology of COPD and Asthma 50
Defining phenotypes of wheeze at preshool age: comparison of episodic vs multi trigger wheeze 50
Lymphoid follicles in end-stage emphysema: Comparison of patients with or without α1-antitrypsin deficiency. 49
Immune Activation in α-1antitrypsin Deficiency Emphysema: Beyond the Protease/Antiprotease Paradigm. 49
Characterization of M1 and M2 macrophages in human lung tissue 48
α1-Antitrypsin Polymerizes in Alveolar Macrophages of Smokers With and Without α1-Antitrypsin Deficiency 48
Heart Failure is Highly Prevalent and Difficult to Diagnose in Severe Exacerbations of COPD Presenting to the Emergency Department 48
Low-Blood Lymphocyte Number and Lymphocyte Decline as Key Factors in COPD Outcomes: A Longitudinal Cohort Study 48
Modulatory effect of atopy on innate immune response to rhinovirus. 47
Non-eosinophilic asathma in children: Mediators of Airway Remodeling Inflammation. 46
Different pathology of pulmonary arterioles in centrilobular and panlobular emphysema 46
Biopatologia delle piccole vie aeree 42
Airway remodelling in children with asthma. 42
Microvesicles in bronchoalveolar lavage as a potential biomarker of COPD 39
Expression of the atypical chemokine receptor D6 in human alveolar macrophages in Chronic Obstructive Pulmonary Disease. 38
Similar adaptive immune response in COPD patients with and without α1 antitrypsin deficiency 38
Air Pollution Relates to Airway Pathology in Wheezing Children 38
Is centrilobular emphysema the link to the Dutch hypothesis? 37
Mast cells in different phenotypes of smokers emphysema. 36
Association between leukocyte telomere length (LTL) and functional decline in patients with Idiopathic Pulmonary Fibrosis (IPF) on antifibrotic treatment 35
Innate lymphoid cells in isocyanate-induced asthma: role of microRNA-155 35
Myeloid derived suppressor cells in the crosstalk between COPD and lung cancer 35
Overexpression of B cell activating factor (BAFF) in peripheral lung of COPD patients. 33
High resolution computed tomography (HRCT) can differentiate rapid from slow progressing Idiopathic pulmonary fibrosis (IPF) 32
Air pollution exposure impairs airway epithelium IFN-β expression in pre-school children 32
Immune activation in alpha1 antitrypsin deficiency (AATD) emphysema: Beyond the protease/antiprotease hypothesis 31
Smoking alters alpha1 antytripsin in alveolar macrophages possibly promoting misfolding 30
Adaptive immune response in COPD patients with and without alpha1 antitrypsin deficiency 30
Distinct clinical and pathological phenotypes in IPF 30
BAL eosinophil counts and specific clinical phenotypes of asthmatic and/or atopic children 29
Lung inflammation and chemokine decoy receptor D6 in COPD. 29
Mucus production, lung inflammation and functional decay in IPF 27
Similar pattern of interleukin-32 in AAT deficient and AAT replete patients with COPD. 26
Decreased epithelial expression of endothelin in children with asthma. 23
Characterization of lymphoid follicles in patients with end-stage emphysema with or without AAT1 deficiency. 2010 American Thoracic Society Conference, May 14-19, New Orleans, Louisiana USA. 21
Epithelial mesenchymal interactions in asthmatic children 17
Circulating extracellular vesicles are associated with disease severity and interleukin-6 levels in copd: A pilot study 15
Severe lung inflammation is a feature of IPF 14
Phenotypes of alveolar macrophages in normal lung and their polarization with disease 12
Mast cell infiltration and epithelial damage in children with episodic wheezing 9
The Emerging Role of Extracellular Vesicles Detected in Different Biological Fluids in COPD 8
Chronic Bronchitis Affects Outcomes in Smokers without Chronic Obstructive Pulmonary Disease (COPD) 5
Symptomatic smokers without COPD have physiological changes heralding the development of COPD 3
Circulating Extracellular Vesicles Are Associated with Disease Severity and Interleukin-6 Levels in COPD: A Pilot Study 2
Differences Between Early- and Late-Onset Asthma: Role of Comorbidities in Symptom Control 1
Totale 4726
Categoria #
all - tutte 7436
article - articoli 5189
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 80
Totale 12705

Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/201892 0000 030 18 10511
2018/2019308 011520 20 1026 4438674
2019/20201071 1251722163 10675 70108 941687647
2020/2021905 19585141 1761 8264 126124126136
2021/20221083 37121133106 6143 70102 762471239
2022/2023544 1778424111 1480 00 0000
Totale 4726